摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-2-[4-[(3-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]phenyl]acetamide | 1241506-98-8

中文名称
——
中文别名
——
英文名称
N-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-2-[4-[(3-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]phenyl]acetamide
英文别名
——
N-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-2-[4-[(3-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]phenyl]acetamide化学式
CAS
1241506-98-8
化学式
C31H34N6OS
mdl
——
分子量
538.717
InChiKey
PYABTSDDKJHZMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.6
  • 重原子数:
    39
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    102
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • TRIAZOLOPYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USE
    申请人:Finch Harry
    公开号:US20120088763A1
    公开(公告)日:2012-04-12
    Compounds of formula (I) are inhibitors of p38 MAP kinase, useful as anti-inflammatory agents in the treatment of inter alia, diseases of the respiratory tract wherein; R 1 is C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, phenyl which is optionally substituted, 5- or 6 membered monocyclic heteroaryl which is optionally substituted, or a radical of formula (II) wherein n is 1 or 2, and R 3 and R 4 are independently H or C 1 -C 6 alkyl, or R 3 and R 4 taken together with the nitrogen to which they are attached form a 6-membered heterocyclic ring optionally containing a further heteroatom selected from N and O; Y is —O— or —S(O) p — wherein p is 0, 1 or 2; A is an optionally substituted divalent arylene radical, or a mono- or bicyclic heteroarylene radical, or a C 3 -C 6 divalent cycloalkylene radical having 5 or 6 ring atoms, or a piperidinylene radical wherein the ring nitrogen is linked to R 2 NHC(═O)W—; W is a bond, —NH— or —C(R A )(R B ), wherein R A and R B are independently H, methyl, ethyl, amino, hydroxyl or halo; and R 2 is a radical as defined in the claims.
    化合物(I)的式子是抑制p38 MAP激酶的,可用于治疗呼吸道疾病等炎症疾病,其中:R1为C1-C6烷基,C3-C6环烷基,苯基(可选取代基),5-或6-成员单环杂芳基(可选取代基),或式子(II)中的基团,其中n为1或2,R3和R4独立地为H或C1-C6烷基,或R3和R4与它们连接的氮一起形成一个6-成员杂环环,该环可选地包含进一步的杂原子,所选自N和O;Y为—O—或—S(O)p—,其中p为0,1或2;A为可选取代的二价芳基基团,或单环或双环杂芳基基团,或具有5个或6个环原子的C3-C6二价环烷基基团,或哌啶基团,其中环氮连接到R2NHC(═O)W—;W为键,—NH—或—C(RA)(RB),其中RA和RB独立地为H,甲基,乙基,基,羟基或卤素;而R2则为声明中所定义的基团。
查看更多